NCT00834756View on ClinicalTrials.gov

Azithromycin 600 Mg Tablets, Fasting

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

October 31, 2002

Study Completion Date

October 31, 2002

Conditions
Healthy
Interventions
DRUG

Azithromycin 600 mg Tablet

1 x 600mg, single-dose fasting

DRUG

Zithromax® 600 mg Tablet

1 x 600mg, single-dose fasting

Trial Locations (1)

63301

Gateway Medical Research, Inc., Saint Charles

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00834756 - Azithromycin 600 Mg Tablets, Fasting | Biotech Hunter | Biotech Hunter